Hims & Hers: telehealth done at scale, with the telehealth tradeoffs

Hims and its sister brand Hers built a business that nobody quite knew they wanted: a phone-based subscription for the prescriptions adults are too embarrassed to ask their GP about. Finasteride for hair loss. Sildenafil for erectile dysfunction. Sertraline for anxiety. Tretinoin for acne. Topical minoxidil, semaglutide off-label for weight loss, melatonin gummies for sleep. The pitch is clean: skip the awkward appointment, fill out a quiz, get the medication shipped in unbranded packaging within a week.

The drugs are real. The doctors are real. The convenience is real. The clinical care, in our reading, is not what most people think they''re paying for.

The receipts. A typical Hims onboarding takes between five and twelve minutes. You answer a structured questionnaire — medical history, current symptoms, contraindications. A licensed clinician (usually a nurse practitioner or physician''s assistant in your state of residence, depending on the product) reviews your answers asynchronously and writes the prescription if you meet the screening criteria. You rarely speak to anyone. You almost never see a face. The medication arrives. It auto-refills monthly until you cancel — and cancellation is, as Reddit will tell you, deliberately friction-heavy.

This is real medicine being prescribed by real prescribers. It is also the most heavily templated, lowest-touch version of clinical practice currently legal in most states. The clinician sees your quiz answers. They do not see your face, your weight on a scale, your blood pressure, your skin, your hair, or the way you hold yourself when you talk about the thing you''re asking for help with. For some of these prescriptions, that''s fine. For others, it matters more than the marketing suggests.

“

For finasteride or topical tretinoin, the asynchronous model is mostly fine. For sertraline or off-label semaglutide, it''s thin care being sold as comprehensive care, and the marketing doesn''t flag the difference.

Where it works. Topical minoxidil and finasteride for male pattern hair loss are well-suited to async telehealth. The diagnosis is largely visual, the side-effect profile is well-mapped, and the medication is identical whether you buy it from Hims, your GP, or a generic pharmacy. The premium you''re paying is for convenience and packaging, not for clinical depth. Same for tretinoin for acne (low risk, well-mapped), and sildenafil for ED without underlying cardiovascular complications.

If you''re buying any of those and the cost works for you, the Hims version is a defensible purchase. You''re not getting worse medicine. You''re getting the same medicine with a subscription wrapper and a better-looking bottle.

Where it gets thinner. SSRIs (sertraline, escitalopram). The Hers psychiatric track prescribes these after an async quiz and a brief video call. SSRIs are genuinely useful drugs for the right person. They are also drugs that interact with bipolar disorder, alcohol use, suicidal ideation history, and a long list of other meds in ways that are difficult to surface in a fifteen-minute structured encounter. The discontinuation syndrome is real and under-discussed. The sexual side effects are real and under-discussed. The need for an actual relationship with a prescriber who can adjust, taper, switch, or refer you onward is real. Hers isn''t built for that. It''s built to start the prescription and refill it.

“

The bottle arrives in unbranded packaging. The taper conversation, if you ever need one, does not.

The same critique applies, harder, to the off-label semaglutide prescriptions Hims rolled out in 2024. Compounded GLP-1 agonists sold via a quiz are a deeply different product to a GLP-1 prescribed by an endocrinologist who is monitoring your A1C, thyroid history, and gastric motility. Both can produce weight loss. Only one is meaningful medical care.

The deeper pattern. Hims solved a real problem: the embarrassment threshold of asking your GP about erectile dysfunction or hair loss was keeping people from getting basic medication that would help them. That''s a genuine public-health win. The company then took the same async-quiz infrastructure and pointed it at categories where the diagnostic conversation matters much more than the prescription itself. The bet is that consumers won''t notice the difference, because to the consumer the experience is identical: fill out form, get pills.

You should notice the difference. For low-stakes, well-mapped prescriptions, async telehealth is fine. For mental health, hormone replacement, weight-loss meds, and anything else where the prescriber needs to actually know you, treat the Hims funnel as a starting point — and then get yourself an actual prescriber.

The clean swap. For hair: a generic compounded topical finasteride from a pharmacy in your country is usually the same active ingredient at a fraction of the price, and a once-or-twice-weekly rosemary scalp serum stacks well on top. For ED: a one-off GP appointment and a generic sildenafil prescription is cheaper long-term and surfaces any cardiovascular issues the quiz won''t catch. For mental health: an actual psychiatrist, even one you see twice a year. Async psychiatry can be the supplement to that relationship. It should not be the relationship itself.

The verdict. Skip the default subscription funnel. Use Hims/Hers selectively, for the categories where async makes sense, and refuse to let it replace clinical care for the categories where it doesn''t. The drugs are real. The convenience is real. The relationship with a clinician — the thing that actually keeps you safe over years, not weeks — isn''t included in the box.

For more on why we outsource medical decisions to apps and what it costs us, see our Kokorology piece on the convenience trap in modern care. The friction we removed was also the friction that kept us safe.

Codex Scorecard

⚠ Skip it

58/100

Composite score

Potency

Solid. The actual drugs (finasteride, minoxidil, sildenafil, SSRIs) work — they are FDA-approved generics.

Bioavailability

Strong. Generics are bioidentical. That is not the problem.

Marketing vs hype vs reality

Weak. The five-minute quiz compresses 'go see a doctor' into 'add to cart'. Async telehealth at scale, with the tradeoffs.

Sustainability

Mixed. Mail-order plastic blister packs. No worse than a pharmacy, no better.

Ethics

Weak. Compounded GLP-1 funnel, subscription lock-in, AI-summarised 'doctor visits' that take 90 seconds.

Verdict

Real prescriptions, thin clinical care, default-funnel upsells.